Because KMT2A was differentially expressed relative to MYC activity in primary PCa versus mCRPC, we next examined potential functional implications of this relationship using the LuCaP PDX cohorts as a model of advanced disease in a series of ChIP-seq experiments. Here, KMT2A is linked to posterior cortical atrophy.